AFFINI-T THERAPEUTICS
Affini-T Therapeutics is a biotechnology company developing T-cell therapies for patients suffering from cancer. Affini-T uses a validated platform to select high-affinity T cell receptors specific to oncogenic mutations to pioneer cutting-edge solid tumor therapies. Affini-T leverages gene editing and synthetic biology to engineer novel T-cell therapies designed to eradicate tumors.
AFFINI-T THERAPEUTICS
Industry:
Biotechnology Health Care Therapeutics
Founded:
2021-01-01
Address:
Watertown, Massachusetts, United States
Country:
United States
Website Url:
http://www.affinittx.com
Total Employee:
101+
Status:
Active
Total Funding:
175 M USD
Technology used in webpage:
Domain Not Resolving U.S. Server Location Comcast JazzHR
Similar Organizations
Alethia BioTherapeutics
Alethia BioTherapeutics is a biotechnology company developing monoclonal antibody-based therapeutics for cancer-associated diseases.
Captain T Cell
Captain T Cell is a start-up project that develops T cell-based immunotherapies for cancer patients.
Century Therapeutics
Century Therapeutics is a developer of allogeneic living drugs created to offer treatment for cancer.
Certa Therapeutics
Certa Therapeutics is a clinical stage biotechnology company developing innovative therapies for the treatment of fibrotic diseases.
Disarm Therapeutics
Disarm Therapeutics is a biotechnology company developing disease-modifying therapeutics for patients with axonal degeneration.
Forge Therapeutics
Forge Therapeutics is a biotechnology company developing novel medicines by combining bio-inorganic with medicinal chemistry.
Io Therapeutics
Io Therapeutics is a biotechnology company developing a series of retinoid and rexinoid compounds.
Juventas Therapeutics
Juventas Therapeutics is a clinical-stage biotechnology company developing regenerative therapies to treat life threatening diseases.
Salvo Health
Launching specialty health clinics to radically improve member outcomes.
Versartis
Versartis is a biotechnology company developing therapeutic proteins for the treatment of endocrine disorders.
Current Employees Featured
Founder
Investors List
Parker Institute for Cancer Immunotherapy
Parker Institute for Cancer Immunotherapy investment in Venture Round - Affini-T Therapeutics
Fred Hutchinson
Fred Hutchinson investment in Venture Round - Affini-T Therapeutics
Agent Capital
Agent Capital investment in Venture Round - Affini-T Therapeutics
Alexandria Venture Investments
Alexandria Venture Investments investment in Venture Round - Affini-T Therapeutics
Humboldt Fund
Humboldt Fund investment in Venture Round - Affini-T Therapeutics
Vida Ventures
Vida Ventures investment in Venture Round - Affini-T Therapeutics
Erasca Ventures
Erasca Ventures investment in Venture Round - Affini-T Therapeutics
Leaps by Bayer
Leaps by Bayer investment in Venture Round - Affini-T Therapeutics
Catalio Capital Management
Catalio Capital Management investment in Venture Round - Affini-T Therapeutics
Key Employee Changes
Official Site Inspections
http://www.affinittx.com Semrush global rank: 5.84 M Semrush visits lastest month: 1.2 K
- Host name: cloudproxy10164.sucuri.net
- IP address: 192.124.249.164
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Affini-T Therapeutics"
Affini-T Therapeutics - Company Profile & Staff Directory
Affini-T is a leading precision immunotherapy company targeting core oncogenic driver mutations to develop potentially curative therapies for patients with solid tumors. Our differentiated cell …See details»
Affini-T Therapeutics - Crunchbase Company Profile
Affini-T Therapeutics is a biotechnology company developing T-cell therapies for patients suffering from cancer. Affini-T uses a validated platform to select high …See details»
Affini-T Therapeutics Company Profile | Management and
Www.affinittx.com Affini-T Therapeutics Profile and History Affini-T Therapeutics is a company that specializes in leveraging synthetic biology and gene editing technologies, allowing teams to …See details»
Affini-T Therapeutics - LinkedIn
Affini-T Therapeutics | 10,089 followers on LinkedIn. Right Targets. Right Cells. Right Place. Unlocking the power of T cells against oncogenic driver mutations. | Affini-T is a leading clinical ...See details»
Affini-T Company Profile 2024: Valuation, Funding
Information on valuation, funding, cap tables, investors, and executives for Affini-T. Use the PitchBook Platform to explore the full profile.See details»
Affini-T Therapeutics - Overview, News & Similar companies
Who is Affini-T Therapeutics. Affini-T Therapeutics is a company that specializes in leveraging synthetic biology and gene editing technologies, allowing teams to overcome key h urdles in …See details»
Affini-T Therapeutics Information - RocketReach
Affini-T is a leading clinical stage precision immunotherapy company targeting oncogenic driver mutations, beginning with KRAS, to develop potentially curative therapies for patients with …See details»
Affini-T Therapeutics Appoints Healthcare Capital Markets Veteran …
Nov 13, 2023 Go Back Affini-T Therapeutics Appoints Healthcare Capital Markets Veteran Kathy Bergsteinsson, MBA, as Chief Financial Officer 11.13.2023. Bergsteinsson brings expertise …See details»
Affini-T Therapeutics Announces Licensing Agreement with …
Apr 13, 2023 [email protected]. More Press Releases. 11.06.2024. Affini-T Therapeutics to Present Trial-in-Progress Poster and Preclinical Data from Its Oncogenic Driver Programs …See details»
Affini-T Therapeutics - Craft
Affini-T Therapeutics has 5 employees across 2 locations. See insights on Affini-T Therapeutics including office locations, competitors, revenue, financials, executives, subsidiaries and more …See details»
Affini-T Therapeutics Appoints Healthcare Capital ... - Business Wire
Nov 13, 2023 For more information, visit affinittx.com and follow us on LinkedIn and X, formerly known as Twitter. Contacts Media Contact Danielle Cantey Evoke Canale …See details»
Affini-T Therapeutics to Present at the 42nd Annual J.P. Morgan ...
BOSTON, January 07, 2024--Affini-T Therapeutics, Inc., a precision immunotherapy company unlocking the power of T cells against oncogenic driver mutations, today announced that Jak …See details»
Affini-T Therapeutics - BIO International Convention | BIO
Jun 7, 2023 Affini-T is unlocking the power of T cells and targeting core oncogenic drivers to develop potentially curative therapies for solid tumors. Our differentiated cell therapy platforms …See details»
Affini-T Therapeutics to Present Data from Its Preclinical Programs ...
May 1, 2024 [email protected]. More Press Releases. 05.28.2024. Affini-T Therapeutics Announces First Patient Dosed in KRAS G12V Phase 1 Program and Presentation of Trial-in …See details»
Affini-T Therapeutics - Company Profile - Tracxn
Oct 30, 2024 Affini-T Therapeutics ranks 82nd among 641 active competitors. 237 of its competitors are funded while 153 have exited. Overall, Affini-T Therapeutics and its …See details»
Affini-T Expands Board of Directors with Appointments of Michael …
Apr 5, 2022 Go Back Affini-T Expands Board of Directors with Appointments of Michael Varney, Ph.D., and Daniel Faga 04.05.2022. BOSTON, Mass., and SEATTLE, Wash. – April 5, 2022 – …See details»
Affini-T Therapeutics Email Format | affinittx.com Emails
[email protected]: 92.9% [first] [email protected]: 7.1%. Email Verification Tool Instantly check any Affini-T Therapeutics email. Get free lookups per month. Verify Top Affini-T …See details»
Affini-T Therapeutics Appoints Jill DeSimone to its Board of Directors
Jul 11, 2022 Go Back Affini-T Therapeutics Appoints Jill DeSimone to its Board of Directors 07.11.2022. BOSTON, Mass., and SEATTLE, Wash. – July 12, 2022 – Affini-T Therapeutics, …See details»
Privacy Policy - Affini-T Therapeutics
If you or your organization would like to explore a partnership with us, we may collect certain information about you, such as your name, e-mail address, phone number, the name of your …See details»